Drug intelligence / Profile preview

cefazolin + metronidazole + lidocaine + epinephrine

Development stage
Preclinical
Lead developer
GSK
Modality
Small Molecules
Administration
Subcutaneous, Infiltration (tumescent Anesthesia)
01

Overview

**Cefazolin + metronidazole + lidocaine + epinephrine** is a multi-drug formulation administered as a tumescent solution, primarily for the prevention of surgical site infections (SSIs) during procedures at high infection risk, such as open colorectal surgery. The antibiotics, **cefazolin** (a first-generation cephalosporin) and **metronidazole** (a nitroimidazole antibiotic), provide broad-spectrum antimicrobial prophylaxis against aerobic and anaerobic bacteria[1][3]. **Lidocaine**, an amide local anesthetic, prevents perioperative pain through sodium channel blockade, while **epinephrine** serves as a local vasoconstrictor to prolong anesthetic action and reduce systemic absorption of lidocaine, improving local drug retention[1][7]. This combination is delivered via **tumescent anesthesia antibiotic delivery (TAAD)**, in which all four components are diluted in saline (with sodium bicarbonate), and infiltrated subcutaneously. This technique achieves high interstitial concentrations of antibiotics, long-lasting anesthesia, and significant local hemostasis[1][3].

Other names
cefazolin + metronidazole + lidocaine + epinephrine
02

Targets

ADRA1A (α1A)NeuraminidaseNaV (Voltage-gated sodium channels)PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on cefazolin + metronidazole + lidocaine + epinephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefazolin + metronidazole + lidocaine + epinephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call